baber/WOPTO huggingface dataset:
Patent NZ-528670-A (NZ)
Title: Removal of scale build-up from a vessel with at least one screen, typically in pulp and paper manufacturing vessels, using cover and chemical
Inventor: ENG GOH HOCK
IPC: C02F1/02
Filed: 2002-04-15
Abstract: A method to remove scale build-up in a vessel having at least one screen is described and involves placing a cover inside the vessel such that it is located beneath at least one screen to separate the screen from the rest of the vessel. The cover in the vessel forms an upper portion and a lower portion in the vessel. Preferably, the cover is in close proximity to the screen which is located in the upper portion of the vessel. The method then further includes introducing a chemical formulation into the upper portion of the vessel in a sufficient amount to remove at least a portion of the scale build-up on the screen. A system to remove scale build-up is also described and includes a vessel having at least one screen. The system further includes a cover located inside the vessel and beneath at least one screen to separate the screen from the rest of the vessel and to form an upper portion and a lower portion in the vessel. Normally the cover is in close proximity to the screen. The system further includes a chemical formulation present in the upper portion of the screen to remove scale build-up. The system of the present invention provide an economical and chemical means to remove scale build-up in vessels that are especially large, such as those used in the paper and pulp manufacturing industry. The present invention further reduces the time needed to remove scale build-up in vessels have one or more screens.
Patent NZ-530278-A (NZ)
Title: Topical composition containing a salicylate derivative for veterinary use in treating dermatological disorders
Inventor: ROSEN STEVEN E
IPC: A61K31/60
Filed: 2002-06-03
Abstract: A method of treating a dermatological disorder of a non-human animal is disclosed, wherein the method comprises topically administering to a dermatological disorder of a non-human animal a therapeutically effective amount of a topical composition containing: (a) an active component comprising at least one salicylate derivative of formula (I); and (b) at least one pharmaceutically acceptable solubilizer, wherein at least a portion of the active component of (a) is at least partially dissolved in the solubilizer. The topical composition described in the said method is suitable for use in veterinary applications.
Patent NZ-533780-A (NZ)
Title: Medicament dispenser
Inventor: ANDERSON GREGOR JOHN MCLENNAN
IPC: A61J7/02
Filed: 2003-01-22
Abstract: A medicament dispenser comprises plural elongate form medicament carriers. Each medicament carrier has multiple distinct medicament dose portions. The medicament dose portion of each carrier contains an active medicament or a mixture of active medicaments which is different from that in the medicament dose portions of the other carriers. The dispenser has a dispensing mechanism which is adapted to operate, upon each actuation of the dispenser, to dispense a single distinct medicament dose portion carried by each of the plural elongate form medicament carriers. The mechanism comprises: a) at least one receiving station for receiving each of the plural medicament carriers; b) a release for releasing in combination a distinct medicament dose portion from each of the plural medicament carriers on receipt thereof by the receiving station; c) an outlet, positioned to be in communication with the distinct medicament dose portions releasable by the release and through which a user is able to access the combination of distinct medicament does portions and d) at least one indexer for individually indexing the distinct medicament dose portions of each of the plural medicament carriers.
Patent NZ-536572-A (NZ)
Title: A clean room with a blower including a hepa filter and ducts
Inventor: SPENGLER CHARLES W
IPC: F24F7/06
Filed: 2003-05-23
Abstract: A system which easily changes a positive pressure space to a negative pressure space or vice versa. The system includes a space divider which forms first and second closed spaces. A blower, and blower duct combination in the first space is connected with one end of an airflow duct in the second space to force air into the second space to create a positive pressure in the second space. For creating a negative pressure in the second space, the blower, blower duct is placed in the second space and an outlet end of the blower duct is connected to another end of the flow duct in the second space to force air from the second space to produce a negative pressure in the second space. The flow duct is provided with apertures in a bottom surface through which air is forced into the second space when a positive pressure space is created. A rolled up flexible sheet is secured at one end of the flow duct to cover apertures in the bottom surface of the flow duct when the blower, and blower duct is connected to the flow duct to create a negative pressure in the second space.
Patent NZ-536664-A (NZ)
Title: Piperazinylpyrazine derivative compounds, their use and preparation
Inventor: NILSSON BJORN
IPC: A61P29/02
Filed: 2003-06-18
Abstract: Piperazinylpyrazine derivative compounds of the general Formula (I) are disclosed, wherein the variables are as defined in the specification. These compounds may be prepared by per se conventional methods and can be used for treating a human or animal subject suffering from a serotonin-related disorder. The disclosure also relates to such use as well as to pharmaceutical compositions comprising a compound of Formula (I).
Patent NZ-538530-A (NZ)
Title: A system for communicating with aircraft components through an onboard microserver web page by wireless means
Inventor: LODA DAVID C
IPC: G06Q10/00
Filed: 2005-03-01
Abstract: A system (10) for communicating with a deployed product is disclosed, where the deployed product is an aircraft engine (50). The system (10) includes an electronic controller (62) which is capable of communication with the deployed product (50) of an aircraft, and a microserver (68) which is communicably coupled to an electronic controller (62). The microserver (68) receives data about the deployed product (50) from the electronic controller (62) and hosts a web page through which the received data is accessible, where the web page has an IP address available for a plurality of Internet protocols. The microserver (68) is a server for all computing devices on board the aircraft and is a client to the Internet. A computing device remote from the deployed product is adapted to wirelessly access the microserver web page.
Patent NZ-543365-A (NZ)
Title: Polymer-conjugated glycosylated neublastin
Inventor: SAH DINAH WEN-YEE
IPC: C12N/
Filed: 2004-04-16
Abstract: Disclosed is a nucleic acid encoding a polypeptide comprising a functional human neublastin and a heterologous signal peptide, wherein the polypeptide lacks the neublastin prodomain. In particular the functional human neublastin is NBN104 and the heterologous signal peptide is the rat albumin signal peptide or the human growth signal. These are preferably expressed in Chinese Hamster Ovary cells.
Patent NZ-548234-A (NZ)
Title: Diagonally twisted sole
Inventor: MUELLER JUNG-SUK
IPC: A43B13/12
Filed: 2005-01-10
Abstract: A diagonally twisted sole (3) consisting of a lower sole (12) and a median sole bottom (11) connected to the lower sole. Various hard inserts (15) can be introduced into the lower sole. Together, the lower sole and a twisted, flexible, rigid or elastic plate (16) can form an intermediate sole (12, 16) which can consist of a plurality of parts. The twisted plate is a flat plate or a plate of various thicknesses.
Patent NZ-555616-A (NZ)
Title: System and methods for fixed-odds based gaming activities
Inventor: AMOUR MARC
Filed: 2007-06-05
Abstract: A method for providing a gaming activity is disclosed wherein a plurality of players provide respective entry fees. The method includes defining respective payout ratios for one or more event outcomes. For each player, entry data indicative of an entry fee and an event outcome is received. For each player, at least a portion of the received entry data to a repository of collective entry data is added. One or more primary entries in relation to a primary gaming activity is allocated to each player on the basis of the entry fee provided by that player and the event outcome selected by that player. In the case that for a given player the selected event outcome is identified as a winning outcome, that player is awarded a primary prize based on the entry fee and the payout ratio defined for the selected event outcome. A database with data indicative of the allocation of the one or more primary entries to each player is updated. A supplementary prize is allocated to at least one player. One or more characteristics of the supplementary prize are determined by reference to one or more characteristics of at least a portion of the collective entry data received at a point in time following the allocation of one or more primary entries to that player.
Patent NZ-570931-A (NZ)
Title: Fermentive production of four carbon alcohols
Inventor: DONALDSON GAIL K
IPC: C12P7/16
Filed: 2007-05-02
Abstract: Disclosed is a recombinant microbial host cell comprising heterologous DNA molecules encoding polypeptides that catalyze the substrate to product conversions: i) pyruvate to alpha-acetolactate; ii) alpha-acetolactate to acetoin; iii) acetoin to 2,3-butanediol; iv) 2,3-butanediol to 2-butanone; and v) 2-butanone to 2-butanol; wherein said microbial host cell produces 2-butanol. Also disclosed is a recombinant microbial host cell comprising heterologous DNA molecules encoding polypeptides that catalyze the substrate to product conversions: i) pyruvate to alpha-acetolactate; ii) alpha-acetolactate to acetoin; iii} acetoin to 2,3-butanediol; and iv) 2,3-butanediol to 2-butanone; wherein said microbial host cell produces 2-butanone.
Patent NZ-572374-A (NZ)
Title: Diarylthiohydantoin compounds
Inventor: YOO DONGWON
IPC: C07D233/86
Filed: 2007-03-29
Abstract: Disclosed is a compound having the formula (I) e.g. 1-(4-Cyano-3-trifluoromethyl-phenyl)-3-[7-(4-cyano-3-trifluoromethyl-phenyl)]-6-thioxo-5-tolyl-5,7-diaza-spiro[3.4]oct-8-ylidene) thiourea wherein R1 and R2 are, together with the carbon to which they are linked, a cycloalkyl group, wherein R3 is selected from the group consisting of dialkylcarbamoylalkyl, and cyanoalkyl, and wherein R4 is hydrogen or fluorine for the treatment of a hyperproliferative disorder. Also disclosed is a method of synthesizing a diaryl compound of formula (I) comprising mixing 4-Isothiocyanato-2-trifluoromethylbenzonitrile with N-Methyl 2-fluoro-4-(1-cyanocyclopentyl)aminobenzamide in a first polar solvent to form a mixture, heating the mixture, adding a second polar solvent, the same as or different from the first polar solvent, and an aqueous acid to the mixture, refluxing the mixture, cooling the mixture and combining with water, and separating the compound from the mixture.
Patent NZ-576164-A (NZ)
Title: Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound
Inventor: YAMAGUCHI YOSHIMASA
IPC: A61P25/00
Filed: 2007-10-15
Abstract: Disclosed is the use of a substituted heterocyclic compound of formula (I) in the manufacture of a medicament for the suppression of one or more mood disorders. Examples of the heterocycle in the compound of formula (I) include: 3,3-dibenzylimidazo[1,2-a]pyridin-2(3H)-one, spiro[imidazo[1,2-a]pyridin-2(3H)-one-3,2'-indan], 3,3-dipropylimidazo[1,2-a]pyridin-2(3H)-one, and 3,3-dibutylimidazo[1,2-a]pyridin-2(3H)-one. Examples of mood disorders are: depression, manic depressive psychoses, obsessive-compulsive disorder, panic disorder, and anxiety disorder.
Patent NZ-582003-A (NZ)
Title: Truss and cementitious building element connected via connector ingtegral with element and accessible to connect to truss
Inventor: LAWLEY DEREK TRENT
IPC: E04B1/18
Filed: 2009-12-14
Abstract: The assembly includes a truss, a fibrous cementitious building element and a connection member wherein the member is integral with the building element and accessible for connection of the truss to the building element. Typically the connection member is a nail plate as a toothed metal shear plate.
Patent NZ-587870-A (NZ)
Title: A remoavble mattress cover with a sleep panel with breathable fabric layers
Inventor: BEARD ALLYN
IPC: A47C27/16
Filed: 2009-03-10
Abstract: A removable mattress cover comprising a sleep panel configured to cover an upper surface of a mattress, the sleep panel comprising: an upper cover layer formed of a breathable fabric; a lower cover layer formed of a breathable fabric; and a resilient and highly breathable three-dimensional spacer layer disposed between the upper and lower cover layers; wherein the upper cover layer, the spacer layer and the lower cover layer are secured by quilting or tufting. A peripheral skirt extends around the edge of the sleep panel for engaging the mattress. The spacer layer is separated into multiple zones of varying resilience and consists of pair of spaced apart outer mesh elements interconnected by an array of spacer yarns extending between and separating said outer mesh elements, or open-cell reticulated foam. The comfort layer of the mattress consists of high density, high resilience foam latex foam, or visco-elastic foam.
Patent NZ-591113-A (NZ)
Title: Thienopyrimidine linked to phenyl or pyridine via an nh amine for pharmaceutical compositions
Inventor: AUSTEN MATTHIAS
IPC: A61P9/00
Filed: 2009-08-24
Abstract: Disclosed are thienopyrimidine-containing compounds and pharmaceutical compositions of Formula (I), salts thereof, and methods for their preparation. Specific examples of compounds of Formula (I) include: Methyl 4-(4-carbamoyl-2-ethoxyphenylamino)-5-methylthieno[2,3-d]pyrimidine-6-carboxylate, 4-(4-Carbamoyl-2-ethoxyphenylamino)-5-methylthieno[2,3-d]pyrimidine-6-carboxamide, 4-(4-Fluoro-2-(tetrahydro-2H-pyran-4-yloxy)phenylamino)-5-methyl-N-(2-morpholinoethyl)thieno[2,3-d]pyrimidine-6-carboxamide, and N-(2-(dimethylamino)ethyl)-5-methyl-4-(2-(tetrahydro-2H-pyran-4-yloxy)pyridin-3-ylamino)thieno[2,3-d]pyrimidine-6-carboxamide. Also disclosed is the use of compounds of Formula (I) in inhibiting the activity of the kinase activity of Mnk1 or Mnk2 (Mnk2a, Mnk2b) or variants thereof. Compounds of Formula (I) are useful for treating cytokine-related disorders, metabolic diseases (such as carbohydrate or lipid metabolism), hematopoietic disorders, neurodegenerative diseases, kidney damage, inflammatory disorders and cancer and their consecutive complications and diseases.
Patent NZ-591913-A (NZ)
Title: High-throughput assay for evaluating dipeptidyl peptidase i (ddpi) activity
Inventor: OLSON MATTHEW
IPC: C07K7/08
Filed: 2009-10-21
Abstract: Disclosed is a method of screening a compound which modulates dipeptidyl peptidase I (DPPI) activities comprises the steps of adding a peptide substrate of DPPI to a reaction mixture which comprises DPPI and a compound, wherein the peptide substrate of DPPI has at least 3 amino acids and binds to a binding site of DPPI in addition to the S1-S2 site; and measuring the molecular weight of the substrate, wherein a change in the molecular weight of the substrate is indicative of the presence of DPPI activity.
Patent NZ-592782-A (NZ)
Title: Bispecific egfr/igfir binding molecules
Inventor: EMANUEL STUART
IPC: C07K14/78
Filed: 2009-11-24
Abstract: Disclosed is an antibody-like protein dimer comprising a tenth fibronectin type III domain (10Fn3) that binds IGF-IR with a KD of less than 500 nM linked to a 10Fn3 that binds EGFR with a KD of less than 500 nM wherein: the IGFIR binding 10Fn3 comprises a BC loop having the amino acid sequence XaSARLKV AXb (SEQ ID NO: 46), a DE loop having the amino acid sequence XcKNVYXd (SEQ ID NO: 48), and an FG loop having the amino acid sequence XeRFRDYQXf(SEQ ID NO: 50); the EGFR binding IOFn3 comprises a BC loop having the amino acid sequence XgWAPVDRYQXh (SEQ ID NO: 137), a DE loop having the amino acid sequence XiRDVYXj (SEQ ID NO: 138), and an FG loop having the amino acid sequence XkDYKPHADGPHTYHESXI (SEQ ID NO: 139); and X is any amino acid and a, b, c, d, e, f, g, h, i, j, k, and 1 are integers independently selected from 0 to 5. Also disclosed is the use of the antibody-like protein dimer for the manufacture of a medicament for treating a hyperproliferative disorder in a subject.
Patent NZ-598018-A (NZ)
Title: Energy dissipative tubes, sealing devices, and methods of fabricating and installing the same
Inventor: DUQUETTE SCOTT
IPC: H02H1/00
Filed: 2010-07-01
Abstract: 598018 A sealing device (1000) for an energy dissipative tube (1002) having a length of tubing (1008), a first resin layer (1010) surrounding the outside of the tubing (1008), a conductive layer (1012) adjacent to the outside of the first resin layer (1010), and a second resin layer (1014) surrounding the conductive layer (1012) and the first resin layer (1010). The device (1000) comprises a split bushing (1100) including one or more penetrating members (1016), (1106a, 1106b) defining at least one tangential cutting edge located on an edge of the split bushing (1100). The tangential cutting edge is adapted and configured to penetrate the second resin layer (1014) and establish electrical continuity with the conductive layer (1012).
Patent NZ-598345-A (NZ)
Title: Methods of treating chronic inflammatory diseases using a gm-csf antagonist
Inventor: YARRANTON GEOFFREY T
IPC: A61K31/505
Filed: 2007-11-21
Abstract: 598345 Disclosed is the use of an anti-GM-CSF antibody for preparing a medicament for reducing the symptoms of rheumatoid arthritis in a patient undergoing treatment with methotrexate without inducing clinically significant neutropenia in which the absolute neutrophil count is less than 0.5 x 109/l, wherein the anti-GM-CSF antibody is a GM-CSF antagonist, and further, wherein the methotrexate is provided to the patient in an amount of 7.5 mg to 25 mg/week and the anti-GMCSF antibody is provided in an amount of 0.1 to 25 mg/week. Further disclosed is the use of an anti-GM-CSF antibody for preparing a medicament for reducing the symptoms of rheumatoid arthritis in a patient undergoing treatment with methotrexate without inducing clinically significant neutropenia in which the absolute neutrophil count is less than 0.5 x 109/l, wherein the anti-GM-CSF antibody is an antagonist and the medicament is formulated for administering the anti-GM-CSF antibody to the patient in an amount of 0.1 to 25 mg/week and the methotrexate is provided in an amount of 0.1 to 25 mg/week.
Patent NZ-600257-A (NZ)
Title: Device and method for delivery of two or more drug agents
Inventor: SANDERS DAVID
IPC: A61M5/00
Filed: 2010-11-29
Abstract: 600257 Disclosed is a device for drug delivery (10). The device (10) has a control unit configured to receive information on a dose of a primary medicament. The control unit is further configured to determine at least one value of a dose of a fluid agent based at least in part on the dose of the primary medicament and a therapeutic dose profile. The therapeutic dose profile is a non-linear profile of the primary medicament and the fluid agent.
Patent NZ-603297-A (NZ)
Title: Separating metal from more volatile component using retort with sublimation of component to produce purified metal with controlled sintering
Inventor: CHRYSS ANDREW
IPC: B01D7/00
Filed: 2011-05-04
Abstract: 603297 A process for recovering metal from a process material comprising the metal and a component that is more volatile than the metal, which process comprises: transporting the process material in a retort provided in a furnace, the retort being operated under vacuum and at a temperature sufficient to cause sublimation of the component from the process material thereby producing purified metal; depositing the component that has been sublimed on a cool surface; removing purified metal from the retort; and removing deposited component from the cool surface.
Patent NZ-605379-A (NZ)
Title: Log loader
Inventor: BRAD A SINTEK
IPC: B66C1/42
Filed: 2013-01-03
Abstract: 605379 A log grapple comprising: a frame; a first arm assembly having a first shaft and at least a first pair of arms mounted along the first shaft, the first shaft coupled to the frame; a second arm assembly having a second shaft and at (east a second pair of arms mounted along the second shaft, the second shaft coupled to the frame; and a first and a second drive wheel, the first drive wheel pivotally coupled to the first shaft between the first pair of arms and the second drive wheel pivotally coupled to the second shaft between the second pair of arms, wherein the first and second pairs of arms are selectively movable from an open position to a closed position, and wherein the first and second drive wheels are selectively movable between an open position and a closed position independently of the first and second pairs of arms.
Patent NZ-615244-A (NZ)
Title: A new adventure sport
Inventor: MANCHAO LI
IPC: A63G31/10
Filed: 2013-09-06
Abstract: Disclosed is an apparatus for adventure sport apparatus which takes the form of a tower. A person stands on a round disk (1) on top of a hydraulic cylinder elevator (2), with no handrail around the person. The hydraulic cylinder (2) rises until the person falls off the disk (1) or waves a pre-set gesture. The goal of this adventure sport is to reach the top without falling or giving up. Safety features may include an air cushion (3), a safety net (4), and a descent control device (6).
Patent NZ-625874-A (NZ)
Title: Heating device or method for repairing or producing components of a wind power plant and parts thereof, and wind power plant
Inventor: MUSCHKE SVEN
IPC: B29C73/34
Filed: 2012-11-12
Abstract: A heating device for use in the repair or production of a rotor blade of a wind power installation, comprising a mat (110) with at least one peripherally extending passage open to one side, and a vacuum tube in the at least one passage. The at least one peripherally extending passage divides the mat into a first and a second portion. At least one heating unit (150) is provided in a region of the first portion such that the air in the region of the first portion can be sucked away by the vacuum tube. At least one first temperature sensor is in the region of the first portion, and a control unit controls the heating unit (150) in dependence on the temperature detected by the first temperature sensor. The control unit controls operation of the heating unit (150) in dependence on the temperature detected by the first and/or second temperature sensor. The control unit perform exothermy detection of a matrix used for repair or production of the component on the basis of the temperature measured by the first and/or second temperature sensor and reduces the heating power output of the heating unit (150) if an exothermy has been detected. The control unit also increases the heating power output of the heating unit (150) upon a decline in exothermy.
Patent NZ-715286-A (NZ)
Title: Fixed and portable coating apparatuses and methods
Inventor: CURRAN SEAMUS
IPC: C23C16/52
Filed: 2014-06-11
Abstract: A system and method for depositing a coating may comprise a coating chemical reactor, surface activation component, and a deposition component. A target surface may be prepared for deposition with the surface activation component. The coating chemical reactor may comprise a coating chemical dispenser and a coating chemical verifier that prepares the coating chemical for deposition. The coating chemical verifier may utilize an optical excitation source and at least one optical detector, wherein chemical substances are identified by unique signatures composed of binary code. The coating chemical may be received by the deposition component to depositing the coating chemical on the target surface. The system and method are suitable for producing complex multi-functional coatings while maintaining its basic nature and portability.